206 related articles for article (PubMed ID: 9067894)
1. Relationship between supersaturation and crystal inhibition in hypercalciuric rats.
Asplin JR; Bushinsky DA; Singharetnam W; Riordon D; Parks JH; Coe FL
Kidney Int; 1997 Mar; 51(3):640-5. PubMed ID: 9067894
[TBL] [Abstract][Full Text] [Related]
2. Dependence of upper limit of metastability on supersaturation in nephrolithiasis.
Asplin JR; Parks JH; Coe FL
Kidney Int; 1997 Dec; 52(6):1602-8. PubMed ID: 9407506
[TBL] [Abstract][Full Text] [Related]
3. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.
Bushinsky DA; Bashir MA; Riordon DR; Nakagawa Y; Coe FL; Grynpas MD
Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084
[TBL] [Abstract][Full Text] [Related]
4. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Laplante K; Asplin JR
Kidney Int; 2006 May; 69(9):1586-92. PubMed ID: 16557225
[TBL] [Abstract][Full Text] [Related]
5. Reduced crystallization inhibition by urine from women with nephrolithiasis.
Asplin JR; Parks JH; Nakagawa Y; Coe FL
Kidney Int; 2002 May; 61(5):1821-9. PubMed ID: 11967033
[TBL] [Abstract][Full Text] [Related]
6. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Parker WR; Asplin JR
Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
[TBL] [Abstract][Full Text] [Related]
7. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR
J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
[TBL] [Abstract][Full Text] [Related]
8. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
[TBL] [Abstract][Full Text] [Related]
9. Reduced crystallization inhibition by urine from men with nephrolithiasis.
Asplin JR; Parks JH; Chen MS; Lieske JC; Toback FG; Pillay SN; Nakagawa Y; Coe FL
Kidney Int; 1999 Oct; 56(4):1505-16. PubMed ID: 10504502
[TBL] [Abstract][Full Text] [Related]
10. Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation.
Tiselius HG; Lindbäck B; Fornander AM; Nilsson MA
Urol Res; 2009 Aug; 37(4):181-92. PubMed ID: 19444436
[TBL] [Abstract][Full Text] [Related]
11. The effect of pH on the risk of calcium oxalate crystallization in urine.
Berg C; Tiselius HG
Eur Urol; 1986; 12(1):59-61. PubMed ID: 3948899
[TBL] [Abstract][Full Text] [Related]
12. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
[TBL] [Abstract][Full Text] [Related]
13. Sulfate but not thiosulfate reduces calculated and measured urinary ionized calcium and supersaturation: implications for the treatment of calcium renal stones.
Rodgers A; Gauvin D; Edeh S; Allie-Hamdulay S; Jackson G; Lieske JC
PLoS One; 2014; 9(7):e103602. PubMed ID: 25061988
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.
Bek-Jensen H; Tiselius HG
Urol Res; 1997; 25(5):365-72. PubMed ID: 9373919
[TBL] [Abstract][Full Text] [Related]
15. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
Robertson WG
Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
[TBL] [Abstract][Full Text] [Related]
16. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
17. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
Schwille PO; Schmiedl A; Herrmann U; Fan J; Gottlieb D; Manoharan M; Wipplinger J
Urol Res; 1999 Apr; 27(2):117-26. PubMed ID: 10424393
[TBL] [Abstract][Full Text] [Related]
18. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
[TBL] [Abstract][Full Text] [Related]
19. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
Bushinsky DA; Neumann KJ; Asplin J; Krieger NS
Kidney Int; 1999 Jan; 55(1):234-43. PubMed ID: 9893132
[TBL] [Abstract][Full Text] [Related]
20. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
Robertson WG
Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
